Ameriprise’s Innovid Corp. CTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,249,167
Closed -$7.65M 4178
2024
Q3
$7.65M Buy
4,249,167
+442,438
+12% +$803K ﹤0.01% 2041
2024
Q2
$7.04M Sell
3,806,729
-475,972
-11% -$1.02M ﹤0.01% 2027
2024
Q1
$10.7M Buy
4,282,701
+202,163
+5% +$350K ﹤0.01% 1725
2023
Q4
$6.12M Sell
4,080,538
-454,677
-10% -$579K ﹤0.01% 2197
2023
Q3
$5.81M Buy
4,535,215
+590,589
+15% +$691K ﹤0.01% 2168
2023
Q2
$4.3M Buy
3,944,626
+1,659,486
+73% +$1.72M ﹤0.01% 2455
2023
Q1
$3.22M Buy
2,285,140
+673,256
+42% +$1.23M ﹤0.01% 2603
2022
Q4
$2.76M Buy
1,611,884
+147,066
+10% +$398K ﹤0.01% 2661
2022
Q3
$3.97M Buy
+1,464,818
New +$4.17M ﹤0.01% 2377

Other funds holding CTV

Ameriprise's CTV Position: Q4 2024 in Review

Ameriprise sold out of Innovid Corp. (CTV) in Q4 2024, closing a stake of 4,249,167 shares — an estimated $7.65M sold.

Ameriprise first reported a position in CTV in Q3 2022 and held it in 9 quarters. The position peaked at $10.7M in Q1 2024. 105 funds tracked by Wall St. Rank hold CTV as of Q4 2024.

  • Ameriprise reported no remaining Innovid Corp. position as of Q4 2024 after selling out during the quarter.
  • Ameriprise sold 4,249,167 Innovid Corp. shares in Q4 2024, an estimated $7.65M.
  • Ameriprise first reported a position in Innovid Corp. in Q3 2022 and held it in 9 quarters.
  • Ameriprise's Innovid Corp. position peaked at $10.7M in Q1 2024.
  • 105 funds tracked by Wall St. Rank held Innovid Corp. as of Q4 2024.

Based on Ameriprise's 13F filing for Q4 2024, filed 14 Feb 2025.